The Future of Oncology Research in a Shifting Policy Landscape

Panelists discuss how evolving policy environments will shape the future of oncology research, access, and innovation. They predict that pricing reforms, value-based reimbursement, and real-world evidence integration will redefine how new therapies are developed and evaluated.

Collaborative partnerships between government, academia, and industry will be essential to sustaining innovation while meeting affordability demands. Panelists emphasize the need to streamline trial design, accelerate data sharing, and foster transparency to adapt to the rapidly changing policy landscape.

Ultimately, they express optimism that thoughtful regulation can catalyze—not constrain—scientific progress, ensuring patients continue to benefit from cutting-edge oncology advancements.